Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alzamend Neuro, Inc

0.6700
+0.00490.74%
Post-market: 0.68900.0190+2.84%19:18 EDT
Volume:90.76K
Turnover:61.06K
Market Cap:4.42M
PE:-0.42
High:0.7035
Open:0.6860
Low:0.6270
Close:0.6651
Loading ...
Nov 08, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 25, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 18, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 30, 2021

Major Issues Report

8-K - Current report
Sep 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 17, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Major Issues Report

8-K - Current report
Aug 04, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jul 29, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 28, 2021

Major Issues Report

8-K - Current report
Jul 23, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 25, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Jun 22, 2021

Major Issues Report

8-K - Current report
Jun 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jun 14, 2021

Correspondence

CORRESP [Cover] - Correspondence